MHRA yellow card: Difference between revisions

It is important for people to report problems experienced with healthcare products as these are used to identify issues which might not have been previously known about. The purpose of the Yellow Card scheme is to provide an early warning that the safety of a product may require more further investigation. The scheme helps the MHRA monitor the safety of all healthcare products in the UK to ensure they are acceptably safe for patients and users. Reports are used alongside other safety information and help the MHRA to take action if any trends associated to the safety or efficacy of a healthcare product are identified. The MHRA will review the issue and if necessary, take action to minimise risk and maximise benefit to the patients.

[[File:Electronic Cigarette Drug Analysis Print up to 30.09.2022.pdf|alt=Report on all adverse events reported by the yellow card scheme|none|thumb|Report on all adverse events reported by the yellow card scheme]]